Literature DB >> 7889643

An epidemiological/genetic study of mental subnormality in Assiut Governorate, Egypt.

S A Temtamy1, M R Kandil, A M Demerdash, W A Hassan, N A Meguid, H H Afifi.   

Abstract

The aim of this investigation was to study the epidemiologic and genetic aspects of mental subnormality (MS) in Assiut Governorate, representing the Egyptian population. The sample comprised 3000 randomly selected subjects from three localities: one urban (Assiut City) and two adjacent rural villages. Age-matched controls were chosen for comparison. The Stanford-Binet test was administered to each individual. During history-taking special attention was paid to consanguinity and categorization on a genetic basis. The results revealed 116 cases with MS, showing an overall prevalence of 3.9%, which varied in the three locations: 3.4% in Assiut City, and 3.8% and 4.4% in the two rural locations. Clinico-genetic classification revealed the following: idiopathic MS 27.6%, MCA/MR syndromes 24.1%, primary CNS defect 12.9%, Martin-Bell syndrome 10.3%, inborn errors of metabolism 9.5%, tetratogenic and environmental causes 5.2%, MS and epilepsy 4.3%, chromosomal disorders 3.4% and MS associated with psychiatric disorder 2.6%. Parental consanguinity was found in 65% of the total sample, which emphasizes the role played by that factor in the etiology of mental subnormality in Egypt.

Entities:  

Mesh:

Year:  1994        PMID: 7889643     DOI: 10.1111/j.1399-0004.1994.tb04176.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Selective screening of amino acid disorders in the south-west of Iran, Shiraz.

Authors:  J Golbahar; Z Karamizadeh; Z Honardar
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

2.  Autosomal recessive mental retardation: homozygosity mapping identifies 27 single linkage intervals, at least 14 novel loci and several mutation hotspots.

Authors:  Andreas Walter Kuss; Masoud Garshasbi; Kimia Kahrizi; Andreas Tzschach; Farkhondeh Behjati; Hossein Darvish; Lia Abbasi-Moheb; Lucia Puettmann; Agnes Zecha; Robert Weissmann; Hao Hu; Marzieh Mohseni; Seyedeh Sedigheh Abedini; Anna Rajab; Christoph Hertzberg; Dagmar Wieczorek; Reinhard Ullmann; Saghar Ghasemi-Firouzabadi; Susan Banihashemi; Sanaz Arzhangi; Valeh Hadavi; Gholamreza Bahrami-Monajemi; Mahboubeh Kasiri; Masoumeh Falah; Pooneh Nikuei; Atefeh Dehghan; Masoumeh Sobhani; Payman Jamali; Hans Hilger Ropers; Hossein Najmabadi
Journal:  Hum Genet       Date:  2010-11-10       Impact factor: 4.132

3.  Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients.

Authors:  A S Soliman; M L Bondy; S A El-Badawy; N Mokhtar; S Eissa; S Bayoumy; I A Seifeldin; P S Houlihan; J R Lukish; T Watanabe; A O Chan; D Zhu; C I Amos; B Levin; S R Hamilton
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

4.  Profile of cystic fibrosis in a single referral center in Egypt.

Authors:  Mona M El-Falaki; Walaa A Shahin; Noussa R El-Basha; Aliaa A Ali; Dina A Mehaney; Mona M El-Attar
Journal:  J Adv Res       Date:  2013-07-15       Impact factor: 10.479

5.  Metabolic screening and its impact in children with nonsyndromic intellectual disability.

Authors:  Yasser F Ali; Salah El-Morshedy; Riad M Elsayed; Amr M El-Sherbini; Saber Am El-Sayed; Nasser Ismail A Abdelrahman; Abdulbasit Abdulhalim Imam
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-19       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.